James M. Daly - Insider Trading & Ownership

Entity: Individual
Location: Incyte Corporation Experimental Station, Rte 141 & Henry Clay Rd. Bldg E336, Wilmington, DE
Summary: The estimated net worth of James M. Daly is at least $2.16M dollars as of February 28, 2025. James M. Daly is the Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $896K. James M. Daly is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $667K. James M. Daly is the Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $577K. James M. Daly is the Director of BELLICUM PHARMACEUTICALS, INC and owns shares of BELLICUM PHARMACEUTICALS, INC stock worth about $21.6K.
All Insider Reports: All Insider Reports

Ownership of James M. Daly

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
HALO	HALOZYME THERAPEUTICS, INC.	Director	$896K			Aug 11, 2023
MDGL	MADRIGAL PHARMACEUTICALS, INC.	Director	$667K	-$5.38M	-89%	Feb 27, 2025
ACAD	ACADIA PHARMACEUTICALS INC	Director	$577K			May 29, 2024
BLCM	BELLICUM PHARMACEUTICALS, INC	Director	$21.6K			Jan 3, 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.